RxDoctor Payments Data

Alexandra Callan, MD

Orthopaedic Surgery · Dallas, TXNPI 1922398312

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (58.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Stryker accounts for 68.2% of it on its own, with 23 other manufacturers making up the rest. 2025 is the largest year on record at $15,964, more than ten times the $1,035 reported in 2019.

$39,411in general payments, 2019–2025

Across 150 payments — averaging $262.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$27K
  • Bone Support Inc.$5K
  • Onkos Surgical, Inc.$3K
  • Musculoskeletal Transplant Foundation Inc.$2K
  • Johnson & Johnson$492
  • Heron Therapeutics, Inc.$359
  • plus $2K from 18 others

What the payments were for

  • Consulting fees$22,94258%
  • Speaking & faculty fees$2,0005%
  • Travel & lodging$6,03215%
  • Food & beverage$8,43721%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$39,411 in reported general payments places this provider in the 85th percentile of 1,337 orthopaedic surgery providers in Texas.

See all orthopaedic surgery providers in Texas →

Medicare billing

Part B allowed, 2024
$58,693
Medicare patients
129
Services billed
477

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl79$610
Celecoxib14$565
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen29$396
Gabapentin21$384
Methocarbamol42$277
Meloxicam22$127
Tramadol Hcl11$51
Ondansetron Hcl18$38

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Dallas

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →